Post Blogs, Photos, Youtube, Vimeo Videos, Topics, Events, Groups.
+ Larger Font | - Smaller Font

Welcome to Robins Social Network

Be part of the community and join us today!

Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs, claims Roots Analysis

In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000+ articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical trials and the grants awarded for STING focused projects in the recent past).


To order this 310+ page report, which features 170+ figures and 200+ tables, please visit this link


The USD 2.8 billion (by 2030) financial opportunity within the STING pathway targeting technologies market has been analysed across the following segments:

§  Types of Payment

§  Upfront Payments

§  Milestone Payments


§  Type of STING Modulator

§  Agonist

§  Antagonist


§  Key Therapeutic Area(s)

§  Oncological Disorders

§  Inflammatory Disorders

§  Infectious Diseases

§  Others


§  Route of Administration

§  Intratumoral

§  Intravenous

§  Oral

§  Subcutaneous

§  Others


§  Type of Molecule

§  Non-nucleotide

§  Cyclic Dinucleotide

§  Live Biotherapeutics

§  Oncolytic Peptides

§  Synthetic Peptides

§  Others


§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific 


The STING Pathway targeting Therapeutics and Technologies, 2020-2030report features the following companies, which we identified to be key players in this domain:

§  Aduro Biotech

§  Bristol Myers Squibb

§  Eisai

§  GlaxoSmithKline

§  ImmuneSensor Therapeutics

§  Merck

§  Noxopharm

§  Spring Bank Pharmaceuticals

§  Synlogic


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. STING Pathway Targeting Therapeutics: Current Market Landscape

5. STING Pathway Targeting Technologies: Current Market landscape

6. Company Profiles

7. Academic Grant Analysis 

8. STING Related Initiatives of Big Pharmaceutical Players

9. Start-up Health Indexing

10. Publication Analysis

11. Partnerships and Collaborations


12. Funding and Investment Analysis

13. Market Sizing and Opportunity Analysis

14. Executive Insights


15. Concluding Remarks


16. Appendix 1: Tabulated Data


17. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415


on January 6 at 9:45

Comments (0)

Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2022 Content By Members. All Rights Reserved.